AI in Healthcare: Hype or Hope? - AstraZeneca at 4YFN 2026

Artificial intelligence is no longer a future promise in healthcare — it is already reshaping how we discover, develop and deliver care. At 4YFN 2026, AstraZeneca brings together global and local perspectives to explore a critical question: is AI in healthcare still hype, or is it delivering real hope and measurable impact?

On March 4th, at the 4YFN Sky Stage, AstraZeneca will host AI in Healthcare: Hype or Hope?, a full-day program that combines science, innovation and real-world execution, reflecting the company’s strong commitment to advancing digital health through collaboration, data-driven science and technology applied at scale.

Morning Session – Science, Innovation & Global Impact from Barcelona

Open to the general public | English | 10:00 to 13:00

The morning sessions will focus on global innovation, scientific progress and the role of technology in transforming healthcare and R&D.

• Opening Keynote – The Power of Artificial Intelligence in a Global Health Hub

  Setting the strategic context for the day, this keynote will outline AstraZeneca’s global innovation vision and how AI, digital technologies and data-driven science are reshaping healthcare, R&D and patient outcomes.

• Digital Twins in Rare Diseases Clinical Development

  An expert roundtable exploring how digital twin technologies are accelerating rare disease research, simulating disease progression and optimizing clinical development in areas of high unmet need.

• From Algorithms to Impact: How Artificial Intelligence Is Transforming Care at Scale

  A discussion on how AI solutions move beyond pilots to deliver measurable impact across healthcare systems.

• AstraZeneca Global Hub in Barcelona: How Tech Is Transforming Care

  A deep dive into how digital tools, data platforms and emerging technologies are enabling more proactive, efficient and patient-centered care models.

• Smarter Trials for a Healthier Future

  A forward-looking conversation on the evolution of clinical trials, exploring how innovation is transforming evidence generation and accelerating patient access.

• The Last Mile of Artificial Intelligence: From Global to Local

  A practical discussion on deploying global AI strategies at local level, drawing on the experience and capabilities of the A.Catalyst Network, a global network of innovation hubs.

Afternoon Session – Turning Innovation into Care at Scale

Private, invitation-only | Spanish | 14:30 to 18:00

The afternoon shifts the focus to real-world implementation, showcasing how innovation is being translated into clinical practice and healthcare system impact.

• Opening the Afternoon – Leading the Transformation of the Healthcare System through a Health Innovation Hub

  An institutional welcome highlighting AstraZeneca’s commitment to healthcare transformation and system-level innovation.

• Human in the Loop: The Next Frontier of Health Innovation

  A keynote emphasizing the essential role of clinicians, patients and healthcare professionals in shaping responsible, trusted and impactful AI-driven innovation.

• AI-Powered Oncology: From Data to Clinical Decisions

  A panel exploring how AI and advanced data platforms are reshaping oncology, from integrated data to clinical decision-making.

• Detecting Signals, Transforming Decisions in the Clinical Setting: Artificial Intelligence and Amyloidosis

  A session focused on how AI-based tools enable earlier detection of transthyretin amyloid disease (ATTR), improving diagnostic pathways and complex clinical decisions.

• When Innovation Becomes #ACCIÓN

  A case-based presentation highlighting success stories from #ACCIÓN, AstraZeneca Spain’s accelerator for innovative health projects, with a special focus on the role of validation centres as key partners in scaling real-world innovation.

• From Reactive to Proactive Care: AI-Driven Early Intervention for Chronic Patients

  Real-world cases demonstrating how AI and clinical data integration enable earlier detection of risk in lupus, severe asthma and COPD, transforming workflows and patient management.

• From Data to Clinical Action in Cardiovascular, Renal and Metabolic Care

  A session exploring how clinical decision support tools and integrated laboratory data improve care pathways for patients with heart failure, diabetes and chronic kidney disease — from lab results to timely clinical action.

Join the Conversation at 4YFN

Beyond the stage, AstraZeneca will also have a strong presence across the official program as a sponsor of the Health Tech vertical at 4YFN 2026, complemented by a dedicated booth showcasing technology demonstrations, partner-led presentations and curated sessions focused on addressing key innovation challenges within healthcare systems.

Join us at 4YFN to explore how AI is moving from hype to hope — and how collaboration is turning innovation into better care, at scale.